306 related articles for article (PubMed ID: 19001931)
1. Is it safe to allow patients with implantable cardioverter-defibrillators to drive? Learnings from a single center experience.
Curnis A; Mascioli G; Bontempi L; Cerini M; Bignotti T; Bonetti G; Dei Cas L
J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1241-5. PubMed ID: 19001931
[TBL] [Abstract][Full Text] [Related]
2. Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators.
; Vijgen J; Botto G; Camm J; Hoijer CJ; Jung W; Le Heuzey JY; Lubinski A; Norekvål TM; Santomauro M; Schalij M; Schmid JP; Vardas P
Europace; 2009 Aug; 11(8):1097-107. PubMed ID: 19525498
[TBL] [Abstract][Full Text] [Related]
3. [Automobile driving and implantable defibrillators].
Lerecouvreux M; Aït Saïd M; Paziaud O; Perrier E; Carlioz R; Lavergne T; Guize L; Le Heuzey JY
Arch Mal Coeur Vaiss; 2005 Apr; 98(4):288-93. PubMed ID: 15881843
[TBL] [Abstract][Full Text] [Related]
4. Resumption of driving after life-threatening ventricular tachyarrhythmia.
Akiyama T; Powell JL; Mitchell LB; Ehlert FA; Baessler C;
N Engl J Med; 2001 Aug; 345(6):391-7. PubMed ID: 11496849
[TBL] [Abstract][Full Text] [Related]
5. [Driving of a motor vehicle after implantation of a cardioverter-defibrillator in malignant heart rhythm disorders. Criteria for the medical assessment of driving fitness in Europe].
Lüderitz B; Jung W
Dtsch Med Wochenschr; 1996 Feb; 121(5):119-23. PubMed ID: 8717193
[TBL] [Abstract][Full Text] [Related]
6. Time to resumption of driving after implantation of an automatic defibrillator (from the Dual chamber and VVI Implantable Defibrillator [DAVID] trial).
Baessler C; Murphy S; Gebhardt L; Tso T; Ellenbogen K; Leman R;
Am J Cardiol; 2005 Mar; 95(5):665-6. PubMed ID: 15721116
[TBL] [Abstract][Full Text] [Related]
7. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
[TBL] [Abstract][Full Text] [Related]
8. Use of beta-blockers in patients with an implantable cardioverter defibrillator.
LaPointe NM; Stafford JA; Pappas PA; Al-Khatib SM; Anstrom KJ
Ann Pharmacother; 2009 Jul; 43(7):1189-96. PubMed ID: 19567655
[TBL] [Abstract][Full Text] [Related]
9. [Restrictions for ICD patients in daily life].
Köbe J; Gradaus R; Zumhagen S; Böcker D
Herz; 2005 Nov; 30(7):625-9. PubMed ID: 16333589
[TBL] [Abstract][Full Text] [Related]
10. Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study.
Albert CM; Rosenthal L; Calkins H; Steinberg JS; Ruskin JN; Wang P; Muller JE; Mittleman MA;
J Am Coll Cardiol; 2007 Dec; 50(23):2233-40. PubMed ID: 18061071
[TBL] [Abstract][Full Text] [Related]
11. The implantable defibrillator and return to operation of vehicles study.
Mylotte D; Sheahan RG; Nolan PG; Neylon MA; McArdle B; Constant O; Diffley A; Keane D; Nash PJ; Crowley J; Daly K
Europace; 2013 Feb; 15(2):212-8. PubMed ID: 22968849
[TBL] [Abstract][Full Text] [Related]
12. Baseline factors predicting early resumption of driving after life-threatening arrhythmias in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.
Hickey K; Curtis AB; Lancaster S; Larsen G; Warwick D; McAnulty J; Mitchell LB
Am Heart J; 2001 Jul; 142(1):99-104. PubMed ID: 11431664
[TBL] [Abstract][Full Text] [Related]
13. [Driving restrictions for arrhythmia patients--with special reference to the implantable cardioverter/defibrillator].
Lüderitz B; Jung W
Z Kardiol; 1996; 85 Suppl 6():115-21. PubMed ID: 9064955
[TBL] [Abstract][Full Text] [Related]
14. Experiences of driving and driving restrictions in recipients with an implantable cardioverter defibrillator--the patient perspective.
Johansson I; Strömberg A
J Cardiovasc Nurs; 2010; 25(6):E1-E10. PubMed ID: 20938245
[TBL] [Abstract][Full Text] [Related]
15. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients.
Alter P; Waldhans S; Plachta E; Moosdorf R; Grimm W
Pacing Clin Electrophysiol; 2005 Sep; 28(9):926-32. PubMed ID: 16176531
[TBL] [Abstract][Full Text] [Related]
16. Low referral rate for prophylactic implantation of cardioverter-defibrillators in a tertiary care medical center.
Bradfield J; Warner A; Bersohn MM
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S194-7. PubMed ID: 19250092
[TBL] [Abstract][Full Text] [Related]
17. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU).
Rosso R; Glick A; Glikson M; Wagshal A; Swissa M; Rosenhek S; Shetboun I; Khalamizer V; Fuchs T; Boulos M; Geist M; Strasberg B; Ilan M; Belhassen B;
Isr Med Assoc J; 2008 Jun; 10(6):435-9. PubMed ID: 18669142
[TBL] [Abstract][Full Text] [Related]
18. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.
Otmani A; Trinquart L; Marijon E; Lavergne T; Waintraub X; Lepillier A; Chatellier G; Le Heuzey JY;
Am Heart J; 2009 Aug; 158(2):230-237.e1. PubMed ID: 19619699
[TBL] [Abstract][Full Text] [Related]
19. Causes of redo procedures in patients with an implantable cardioverter-defibrillator--long-term follow-up results.
Gepner K; Przybylski A; Maciag A; Sterliński M; Lewandowski M; Syska P; Kowalik I; Szwed H
Kardiol Pol; 2007 Aug; 65(8):893-8; discussion 899. PubMed ID: 17853318
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
